Interested in combining research with your clinical work? This Grand Round features clinician scientists from the Department of General Medicine. You will hear about their diverse career pathways and research programs, as well as how they balance research with their clinical work and other commitments.
The Vernon Collins Oration was established in 1981, in memory of Professor Vernon Collins, the first Medical Director of The Royal Children’s Hospital, Melbourne. He held this position from 1949 to 1960 and then became the Professor of Child Health in the University of Melbourne, before retiring in 1974.
Illness and separation at a critical time for infant-parent attachment have adverse effects on infant and parent mental health. COCOON, which stands for the Circle of Care Optimising Outcomes for Newborns, is the patient-centred, family-integrated and baby-led model of care we designed to minimise these adverse effects in the complex medical and surgical NICU population, although the core principles can be applied in any healthcare setting.
Sibling sexual abuse is 3-5 times more common than father/step-father abuse. This study looked past the factors that might contribute to the occurrence of sibling sexual abuse with the aim of better understanding the experience of therapists working with families with such experience and collaboratively developing principles to guide practice in this complex area of child sexual abuse.
The Colorectal and Pelvic Reconstruction Service was created in 2019 to provide world-class care for children and families affected by complex colorectal conditions. Through the combined support of the RCH Foundation, the Victorian Government and the Federal Government, the service acts as a national leader for children born with anorectal malformations or Hirschsprung disease, and children affected by chronic constipation.
Victoria’s newborn bloodspot screening (NBS) program commenced in 1966 with screening for phenylketonuria, and from the early 1970’s close to 100% of newborns were being screened. Improvements in analytical and genetic testing technologies saw the successive introduction of screening for congenital hypothyroidism, cystic fibrosis and 22 metabolic conditions. Today, Victoria’s NBS program detects about 80 babies per year with these conditions, preventing life-long debilitating outcomes and even death.
Among individuals with cerebral palsy (CP), rehabilitation needs and treatment have been established, but are mostly focused on the pediatric population. Evidence demonstrates that the number of adults who live with CP and other childhood-onset disabilities is increasing, and that they experience significant physical and mental health inequalities as they grow up.
Traditionally being considered a method for training healthcare professionals in basic and advanced life support, Simulation Based Education in healthcare has grown over the past 30 years and is now recognised to be effective in many other aspects of healthcare training. Focusing on enhancing patient safety, simulation initially concentrated on clinical procedural skills training and immersive deteriorating patient simulations, as well as simulations to enhance communication between staff and with patients and their families.
The Royal Children’s Hospital Children’s Bioethics Centre has recently appointed the first Bioethics Clinical Nurse Consultant, Dr Jenny O’Neill. In this Grand Round, we introduce Jenny, and explore the role of the nurse ethicist and the value they can bring to a healthcare service. We will highlight the unique perspective that a nursing background brings to ethical deliberation and clinical ethics consultation.
Over recent years the number of children with advanced heart failure from cardiomyopathy and congenital heart disease receiving treatment has increased considerably. The Royal Children’s Hospital has been the nationally funded centre for heart transplantation in children for 30 years. The RCH heart failure program involves medical, surgical, nursing, allied health and biomedical technology. Successful management of severe heart disease in children requires a detailed understanding of the aetiology, likely disease trajectory and balancing an increasing number of treatment options.
